Covered recipient · General Payments record
STEVEN HWANG
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2024
$850.82
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $850.82 | 42 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $79.25 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.21 | 3 |
| Incyte Corporation | $49.76 | 2 |
| PFIZER INC. | $49.24 | 3 |
| Sumitomo Pharma America, Inc. | $48.34 | 2 |
| Alexion Pharmaceuticals, Inc. | $43.52 | 2 |
| E.R. Squibb & Sons, L.L.C. | $39.30 | 2 |
| EISAI INC. | $37.52 | 2 |
| BeiGene USA, Inc. | $36.70 | 2 |
| Acerta Pharma LLC | $34.71 | 2 |
| ABBVIE INC. | $31.26 | 1 |
| CSL Behring | $29.38 | 1 |
| Myriad Genetic Laboratories, Inc. | $27.26 | 2 |
| SOBI, INC | $26.23 | 1 |
| Janssen Scientific Affairs, LLC | $25.70 | 1 |
| Genmab U.S., Inc. | $23.62 | 1 |
| Genentech USA, Inc. | $23.23 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.23 | 1 |
| Merck Sharp & Dohme Corporation | $20.14 | 1 |
| Coherus Biosciences Inc. | $19.99 | 1 |
| Adaptive Biotechnologies Corporation | $18.06 | 1 |
| Astellas Pharma US Inc | $17.43 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.91 | 1 |
| Janssen Biotech, Inc. | $16.20 | 1 |
| Gilead Sciences, Inc. | $15.66 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.40 | 1 |
| GlaxoSmithKline, LLC. | $14.35 | 1 |
| Iovance Biotherapeutics, Inc. | $13.22 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $850.82 | 42 |
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.